The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Isoptin 2.5mg/ml Solution for Injection or Infusion



Mylan IRE Healthcare LimitedPA2010/003/004

Main Information

Trade NameIsoptin 2.5mg/ml Solution for Injection or Infusion
Active SubstancesVERAPAMIL HYDROCHLORIDE
Dosage FormSolution for injection/infusion
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/003/004

Group Information

ATC CodeC08DA Phenylalkylamine derivatives
C08DA01 verapamil

Status

License statusAuthorised
Licence Issued01/04/1980
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back